# FDA Inspection 1191818 - Intas Pharmaceuticals Limited - December 02, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/c40b512c-7d12-45b2-bbd7-edc2eba3727a/
Source feed: FDA_Inspections

> FDA Inspection 1191818 for Intas Pharmaceuticals Limited on December 02, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191818
- Company Name: Intas Pharmaceuticals Limited
- Inspection Date: 2022-12-02
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1119170 - 2020-02-28](https://www.globalkeysolutions.net/api/records/fda_inspections/intas-pharmaceuticals-limited/43470247-9a87-4de0-a9c2-c9ce8fac49f7/)
- [FDA Inspection 1092798 - 2019-05-28](https://www.globalkeysolutions.net/api/records/fda_inspections/intas-pharmaceuticals-limited/5e800bc2-1d9a-499d-9ff0-7b46771cff99/)
- [FDA Inspection 992746 - 2016-10-19](https://www.globalkeysolutions.net/api/records/fda_inspections/intas-pharmaceuticals-limited/a5863c26-41da-447a-b925-1bc399b01e2a/)
- [FDA Inspection 910188 - 2014-12-19](https://www.globalkeysolutions.net/api/records/fda_inspections/intas-pharmaceuticals-limited/ecfd7d9b-83bb-4179-be43-4cc30e94f0e8/)
- [FDA Inspection 847008 - 2013-06-27](https://www.globalkeysolutions.net/api/records/fda_inspections/intas-pharmaceuticals-limited/2b1c7e62-59b2-4b67-9f2a-36f55b1ee69f/)

Company: https://www.globalkeysolutions.net/companies/intas-pharmaceuticals-limited/cfedbb2f-5587-42dc-985b-044083dd01e5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c